Cognition Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.858; its P/E ratio is -2.33; Cognition Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -25.24M	$ -14.43M	$ -4.72M	$ -6.16M	$ 1.21M
EBITDA	$ -25.18M	$ -14.37M	$ -4.66M	$ -6.10M	$ 1.27M
Net Income Common Stockholders	$ -457.00K	$ -14.43M	$ -4.73M	$ -6.17M	$ -5.18M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 29.92M	$ 32.97M	$ 37.19M	$ 38.81M	$ 41.56M
Total Assets	$ 35.16M	$ 38.77M	$ 43.96M	$ 45.41M	$ 50.42M
Total Debt	$ 694.00K	$ 735.00K	$ 774.00K	$ 808.00K	$ 844.00K
Net Debt	$ -29.23M	$ -32.23M	$ -36.42M	$ -38.00M	$ -40.72M
Total Liabilities	$ 10.69M	$ 9.85M	$ 9.57M	$ 9.88M	$ 50.42M
Stockholders Equity	$ 24.47M	$ 28.93M	$ 34.39M	$ 35.78M	$ 40.25M
Cash Flow	-
Free Cash Flow	$ -5.49M	$ -4.22M	$ -3.71M	$ -2.75M	$ -10.19M
Operating Cash Flow	$ -5.46M	$ -4.16M	$ -3.70M	$ -2.71M	$ -10.18M
Investing Cash Flow	$ -30.00K	$ -58.00K	$ -18.00K	$ -41.00K	$ -10.00K
Financing Cash Flow	$ 2.44M	$ -3.00K	$ 2.10M	$ -10.00K	$ 5.14M

Currency in USD

Cognition Therapeutics Earnings and Revenue History

Income Statement >

Cognition Therapeutics Debt to Assets

Balance Sheet >

Cognition Therapeutics Cash Flow

Cash Flow >

Cognition Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing